Ninety One North America’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-115,322
Closed -$11.9M 110
2021
Q4
$11.9M Sell
115,322
-1,657
-1% -$192K 0.42% 45
2021
Q3
$14.7M Buy
116,979
+826
+0.7% +$107K 0.68% 29
2021
Q2
$14.4M Sell
116,153
-773
-0.7% -$97.1K 0.68% 34
2021
Q1
$13.8M Buy
116,926
+16,801
+17% +$1.97M 0.8% 31
2020
Q4
$11.7M Buy
100,125
+55,290
+123% +$6.09M 0.72% 35
2020
Q3
$4.66M Sell
44,835
-715
-2% -$71.8K 0.51% 52
2020
Q2
$4.18M Sell
45,550
-28,499
-38% -$2.73M 0.43% 48
2020
Q1
$6.68M Buy
74,049
+3,637
+5% +$387K 0.55% 46
2019
Q4
$7.99M Buy
+70,412
New +$7.73M 0.65% 40
2016
Q4
Sell
-93,999
Closed -$8.12M 117
2016
Q3
$8.12M Buy
93,999
+3,000
+3% +$261K 1.09% 47
2016
Q2
$7.9M Sell
90,999
-21,337
-19% -$1.73M 1.16% 49
2016
Q1
$8.43M Buy
112,336
+4,270
+4% +$322K 1.4% 34
2015
Q4
$8.31M Buy
108,066
+27,162
+34% +$2.04M 1.47% 36
2015
Q3
$5.42M Sell
80,904
-1,379
-2% -$102K 1.37% 40
2015
Q2
$6.1M Sell
82,283
-10,943
-12% -$836K 1.96% 29
2015
Q1
$7.27M Buy
93,226
+84,159
+928% +$6.38M 2.26% 18
2014
Q4
$655K Buy
+9,067
New +$630K 0.19% 79

Other funds holding MDT

Ninety One North America's MDT Position: Q1 2022 in Review

Ninety One North America sold out of Medtronic (MDT) in Q1 2022, closing a stake of 115,322 shares — an estimated $11.9M sold.

Ninety One North America first reported a position in MDT in Q4 2014 and held it in 17 quarters. The position peaked at $14.7M in Q3 2021. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Ninety One North America reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Ninety One North America sold 115,322 Medtronic shares in Q1 2022, an estimated $11.9M.
  • Ninety One North America first reported a position in Medtronic in Q4 2014 and held it in 17 quarters.
  • Ninety One North America's Medtronic position peaked at $14.7M in Q3 2021.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Ninety One North America's 13F filing for Q1 2022, filed 27 Apr 2022.